c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells

P Cirri1, P Chiarugi, F Marra

  • 1Dipartimento di Scienze Biochimiche, Instituto di Medicina Interna, Università di Firenze, Italy.

Insights

Cellular Src tyrosine kinase activates STAT1 and STAT3 signaling pathways. This study demonstrates c-Src

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Signal transduction pathways

Background:

  • Signal transducer and activator of transcription (STAT) proteins, specifically STAT1 and STAT3, are activated by growth factors like PDGF and EGF.
  • STAT activation involves tyrosine phosphorylation, dimerization, and nuclear translocation to act as transcription activators.
  • The role of Src family kinases in STAT activation, particularly in response to growth factors, is not fully understood.

Purpose of the Study:

  • To investigate the role of cellular Src (c-Src) tyrosine kinase in the activation of STAT1 and STAT3 signaling pathways.
  • To determine if c-Src directly interacts with STAT1 and STAT3 during growth factor-induced signaling.

Main Methods:

  • Utilizing NIH3T3 cells stimulated with Platelet-Derived Growth Factor (PDGF).
  • Overexpression of c-Src and dominant-negative Src constructs.
  • Assessing tyrosine phosphorylation and DNA binding activity of STAT1 and STAT3.
  • Performing co-immunoprecipitation assays to detect protein interactions.

Main Results:

  • c-Src overexpression up-regulated both tyrosine phosphorylation and DNA binding activity of STAT1 and STAT3.
  • Dominant-negative Src expression inhibited STAT1 and STAT3 activation.
  • STAT1 was found to co-immunoprecipitate with c-Src, indicating a direct interaction.

Conclusions:

  • Cellular Src tyrosine kinase plays a significant role in the activation of both STAT1 and STAT3.
  • c-Src directly interacts with STAT1, suggesting a mechanism for STAT activation in PDGF signaling.
  • These findings elucidate a novel role for c-Src in growth factor receptor signal transduction.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...